Identification of a Lysosomal Pathway That Modulates Glucocorticoid Signaling and the Inflammatory Response

Laboratory of Structural Sciences, Van Andel Research Institute, 333 Bostwick Avenue Northeast, Grand Rapids, MI 49503, USA.
Science Signaling (Impact Factor: 6.28). 07/2011; 4(180):ra44. DOI: 10.1126/scisignal.2001450
Source: PubMed


The antimalaria drug chloroquine has been used as an anti-inflammatory agent for treating systemic lupus erythematosus and rheumatoid arthritis. We report that chloroquine promoted the transrepression of proinflammatory cytokines by the glucocorticoid receptor (GR). In a mouse collagen-induced arthritis model, chloroquine enhanced the therapeutic effects of glucocorticoid treatment. By inhibiting lysosome function, chloroquine synergistically activated glucocorticoid signaling. Lysosomal inhibition by either bafilomycin A1 (an inhibitor of the vacuolar adenosine triphosphatase) or knockdown of transcription factor EB (TFEB, a master activator of lysosomal biogenesis) mimicked the effects of chloroquine. The abundance of the GR, as well as that of the androgen receptor and estrogen receptor, correlated with changes in lysosomal biogenesis. Thus, we showed that glucocorticoid signaling is regulated by lysosomes, which provides a mechanistic basis for treating inflammation and autoimmune diseases with a combination of glucocorticoids and lysosomal inhibitors.

Download full-text


Available from: Jeffrey P MacKeigan, Sep 19, 2014
  • Source
    • "The Halo tag technology has been applied to label β1-integrin with the substrate linked to Atto655 in STED (Stimulated emission depletion) microscopy (Schroder et al., 2009), to investigate peroxisome dynamics (Huybrechts et al., 2009), to image tumors in various colors in live animals (Kosaka et al., 2009) and to label proteins in bacteria and mammalian cells for super-resolution imaging (Lee et al., 2010). In addition, Halo tag has proven useful for CALI applications using an eosin ligand and pulse-chase experiments to examine the stability of receptor proteins (He et al., 2011). As a functional extension of this tagging approach, Neklesa et al. designed a small molecule induced degradation system in which a hydrophobic moiety is linked to the Halo tag ligand (Neklesa et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The pursuit of quantitative biological information via imaging requires robust labeling approaches that can be used in multiple applications and with a variety of detectable colors and properties. In addition to conventional fluorescent proteins, chemists and biologists have come together to provide a range of approaches that combine dye chemistry with the convenience of genetic targeting. This hybrid-tagging approach amalgamates the rational design of properties available through synthetic dye chemistry with the robust biological targeting available with genetic encoding. In this review, we discuss the current range of approaches that have been exploited for dye targeting or for targeting and activation and some of the recent applications that are uniquely permitted by these hybrid-tagging approaches.
    Full-text · Article · Mar 2015 · Cell and Tissue Research
  • Source
    • "Two cell lines with different characteristics were used for the transfection and the subsequent dual luciferase reporter assay: AD293 and SW962. AD293 (which is commonly used for dual luciferase reporter assays [21, 22]), contained only wild-type TP53 and constituted the normal sample. SW962 was chosen as a cell line with heterozygous mutation of TP53. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Previously we have suggested that cancer cells develop a mechanism(s) which allows for either: silencing of the wild-type TP53 transcription, degradation of the wild-type TP53 mRNA, or selective overproduction of the mutated TP53 mRNA, which is the subject of this article. Sequencing of TP53 on the respective cDNA and DNA templates from tumor samples were found to give discordant results. DNA analysis showed a pattern of heterozygous mutations, whereas the analysis of cDNA demonstrated the mutated template only. We hypothesized that different TP53 gene expression levels of each allele may be caused by the polymorphism within intron 3 (PIN3). The aim of this study was to test if one of the polymorphic variants of PIN3 (A1 or A2) in the heterozygotes is associated with a higher TP53 expression, and therefore, responsible for the haploinsufficiency phenomenon. 250 tumor samples were tested. To analyze the involvement of PIN3 polymorphic variant (A1 or A2) on TP53 mRNA expression regulation, bacterial subcloning combined with sequencing analyses, dual luciferase reporter assays and bioinformatic analysis were performed. Haplotype analysis showed the predominance of the mutated template during the cDNA sequencing in all samples showing a heterozygous TP53 mutation and PIN3 heterozygosity. Out of 30 samples (from the total of 250 tested samples) which carried TP53 mutations and had a bias in allelic expression 6 were heterozygous for the A1/A2 polymorphism, and all 6 (p = 0.04) samples carried the mutation within the PIN3 longer allele (A2). Reporter assays revealed higher luciferase activity in cells transfected with the plasmid containing A2 construct than A1 and control. A2/A1 ratio ranged from 1.16 for AD293 cell line (p = 0.019) to 1.59 for SW962 cell line (p = 0.0019). Moreover, bioinformatic analyses showed that PIN3 duplication stabilized secondary DNA structures – G-quadruplexes. TP53 alleles are not equivalent for their impact on the regulation of expression of TP53 mRNA. Therefore, in PIN3-heterozygous cases a single TP53 mutation of the longer allele might sufficiently destabilize its function. Secondary DNA structures such as quadruplexes can also play a role in PIN3-dependent TP53 haploinsufficiency.
    Full-text · Article · Sep 2014 · BMC Cancer
  • Source
    • "Indeed, biochemical experiments performed in rat uterine cells showed that radioactive E2 has been found in sub-cellular fractions corresponding to the lysosome-enriched compartment [14], gold-labelled E2 conjugated with BSA (i.e., gold E2-BSA) was observed in lysososmes of HepG2 cells by electron microscopy [15] and fluorescent labelled E2-BSA or transfected GFP-tagged ERα were separately shown to co-localize with lysotracker in NR-38 neurons [16]. Moreover, the glucocorticoid receptor degradation was found to be partially dependent on lysosomes in modified human embryonic kidney AD293 cells [29]. Thus, lysosome-based degradation contributes to the regulation of the cellular content of both ERα and other nuclear receptors. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The homeostatic control of the cellular proteome steady-state is dependent either on the 26S proteasome activity or on the lysosome function. The sex hormone 17β-estradiol (E2) controls a plethora of biological functions by binding to the estrogen receptor α (ERα), which is both a nuclear ligand-activated transcription factor and also an extrinsic plasma membrane receptor. Regulation of E2-induced physiological functions (e.g., cell proliferation) requires the synergistic activation of both transcription of estrogen responsive element (ERE)-containing genes and rapid extra-nuclear phosphorylation of many different signalling kinases (e.g., ERK/MAPK; PI3K/AKT). Although E2 controls ERα intracellular content and activity via the 26S proteasome-mediated degradation, biochemical and microscopy-based evidence suggests a possible cross-talk among lysosomes and ERα activities. Here, we studied the putative localization of endogenous ERα to lysosomes and the role played by lysosomal function in ERα signalling. By using confocal microscopy and biochemical assays, we report that ERα localizes to lysosomes and to endosomes in an E2-dependent manner. Moreover, the inhibition of lysosomal function obtained by chloroquine demonstrates that, in addition to 26S proteasome-mediated receptor elimination, lysosome-based degradation also contributes to the E2-dependent ERα breakdown. Remarkably, the lysosome function is further involved in those ERα activities required for E2-dependent cell proliferation while it is dispensable for ERα-mediated ERE-containing gene transcription. Our discoveries reveal a novel lysosome-dependent degradation pathway for ERα and show a novel biological mechanism by which E2 regulates ERα cellular content and, as a consequence, cellular functions.
    Full-text · Article · Apr 2014 · PLoS ONE
Show more